Klogene Therapeutics, Inc.
PrivateCompany Overview
Klogene Therapeutics, Inc. is a biotechnology company that develops novel neuroprotective therapeutics for neurodegenerative diseases by modulating the expression of the Klotho protein.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
neurodegenerative diseaseKlotho proteingene therapysmall molecule drugsCRISPRAAV gene therapylongevity researchneuroprotectionAlzheimer's researchvirtual biotechdrug discoverybiotech startuppreclinical developmentanti-aging medicinecontract research organizationCRO
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Klogene Therapeutics, Inc. Comparables
Compare Klogene Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jocasta Neuroscience | 88% | |
| ADvantage Therapeutics Inc. | 86% | |
| Klotho Neurosciences, Inc. | 84% | |
Klogene Therapeutics, Inc. Funding Rounds
Historical fundraising activity
Klogene Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Klogene Therapeutics, Inc.'s valuation, stock price, and market status.